Back to search

Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, 1994: THE ALLOMETRIC APPROACH FOR INTERSPECIES SCALING OF PHARMACOKINETICS AND TOXICITY OF ANTI‐CANCER DRUGS

Data up to Jan 2025

Published1995
Citations20
References27

Total Citations Per Year

Abstract

References (27)

Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

1966 • 1,363 citations

Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics

1982 • 629 citations

Principles and methods of toxicology

1995 • 407 citations

Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to benzodiazepines and phenytoin

1980 • 340 citations

Interspecies Pharmacokinetic Scaling and the Evolutionary-Comparative Paradigm

1984 • 271 citations

Pharmacologically Guided Phase I Clinical Trials Based Upon Preclinical Drug Development

1990 • 208 citations

Biological basis for extrapolation across mammalian species

1986 • 161 citations

Interspecies scaling and comparisons in drug development and toxicokinetics

1990 • 150 citations

The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man

1970 • 147 citations

Prediction of the disposition ofβ-lactam antibiotics in humans from pharmacokinetic parameters in animals

1984 • 119 citations

Extrapolation of Toxicological and Pharmacological Data from Animals to Humans

1991 • 104 citations

Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species

1984 • 86 citations

Interspecies Extrapolation: A Reexamination of Acute Toxicity Data

1992 • 69 citations

The allometric approach for interspecies scaling of pharmacokinetic parameters

1992 • 61 citations

Interspecies Correlation of the Pharmacokinetics of Erythromycin, Oleandomycin, and Tylosin

1985 • 57 citations

Cyclosporine pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans.

1988 • 55 citations

Dosage Regimen Design for Pharmaceutical Studies Conducted in Animals

1986 • 50 citations

Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humans.

1990 • 46 citations

Problems and opportunities in toxicity testing arising from species differences in xenobiotic metabolism

1992 • 43 citations

Suitability of Animal Models for Predictive Toxicology: Theoretical and Practical Considerations

1984 • 33 citations

Physiological pharmacokinetic models: principles, applications, limitations and outlook.

1986 • 33 citations

Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.

1986 • 32 citations

Interspecies Metabolism and Pharmacokinetic Scaling of Theophylline Disposition

1990 • 29 citations

Phencyclidine pharmacokinetic scaling among species.

1987 • 26 citations

New Approaches to the Use of Pharmacokinetics in Toxicology and Drug Development

1988 • 25 citations

Prediction of ACNU plasma concentration-time profiles in humans by animal scale-up

1990 • 17 citations

Isomerisation and urinary excretion of proxibarbal and valofan in man; a preliminary study

1984 • 8 citations

Cited By (0)

Loading...
Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists,… (1995) – Clinical and Experimental Pharmacology and Physiology | Metascience Observatory Explorer